Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q2 2026 · 10-Q
Revenue—
Net Income-$1.25M-$1.25MN/M vs Q2 2025 EPS Diluted-$0.92-$0.92N/M vs Q2 2025 Operating Income-$1,278,000N/M Operating Cash Flowderived-$2,001,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 19, 2026 · 50 d after period end